The global empty capsules market is projected to generate USD 4,879 million revenue by 2030, advancing at a CAGR of 7.10% during 2022–2030. This is attributed to the rising prevalence of diseases, growing geriatric population, and booming pharmaceutical and nutraceutical industries.
The global market is also projected to be driven by the increasing commercialization of gelatin capsule-based medication delivery systems. The consumption of nutraceuticals in the gelatin capsule form has increased as a result of the growing knowledge of healthy lifestyle choices. The key characteristics of these capsules are high bioavailability and easy digestibility. Additionally, due to their distinctive nutritional qualities, capsule dosage forms have seen an evolution in their use in nutraceuticals over time.
Moreover, the prevalence of all kinds of diseases, especially the chronic ones, is rising due to the sedentary lifestyles. As a result, the manufacturing of therapeutics is rising globally, which is leading to the growth of the market.
The nutraceutical industry will witness the fastest growth during the prediction period. Empty supplement and vitamin capsule sales have increased because of the growing consumption of nutraceuticals to get proper nutrition. Furthermore, the demand for nutraceuticals is growing due to the rising prevalence of infectious diseases and the unbalanced diet. Most of the nutraceuticals are consumed in the capsule form, which drives the market growth.
Based on end user, the pharmaceutical industry held the largest revenue share in 2022, and it is further expected to maintain its dominance during the forecast period. The pharmaceutical sector has the highest need for these empty capsules to produce drugs for a wide range of chronic and infectious diseases because capsules are the desired solid dosage form due to their greater palatability and a faster absorption inside the body. Moreover, this category is being propelled by the constant advancements in the pharmaceutical industry and rising frequency of chronic illnesses throughout the world.
The APAC region is expected to grow the fastest in the empty capsules market over the forecast period. The growth of the pharmaceutical industry, supportive government initiatives for the construction of the healthcare infrastructure, and rising demand for nutraceuticals and cosmeceuticals as a result of the increasing awareness of wellness trends and the changing lifestyles with a focus on fitness are the main contributing factors. Moreover, the rising focus of the market players on manufacturing therapeutics and nutraceuticals in the region drives the market here.
Among all regional countries, China leads the market. It can be mainly attributed to the high investments being made by the market players in the field of life sciences for manufacturing therapeutics and nutraceuticals. Additionally, the rising prevalence of chronic and infectious diseases in the country is another factor behind the growth of the market.
Moreover, the market in Japan is expected to grow at a healthy rate owing to the increasing usage of all kinds of medications by the geriatric population and the growing consumer knowledge of the advantages of capsules over other forms.
The market in India is also growing due to the government support to boost pharmaceutical manufacturing. The country is home to a huge population, which contributes to the high prevalence of diseases. To reduce this burden, the government is planning to speed up the setup of pharmaceutical manufacturing plants. Moreover, the growing awareness of nutraceuticals and immunity in the country has led to the adoption of nutraceuticals, thus propelling the market.
Some of the major market players are ACG Group, SavoiurCaps, Comed Chemicals Limited, Capscanada Corporation, Medi-Caps Ltd., Bright Pharma Caps Inc., Lonza Group AG, Qingdao Yiqing Medicinal Capsules Co. Ltd., and Healthcaps India Ltd.